Switch theme
Sign up to access all valuation multiples
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.
2004
1.0K+
LTM Revenue $178M
LTM EBITDA -$24.4M
$1.0B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Establishment Labs has a last 12-month revenue of $178M and a last 12-month EBITDA of -$24.4M.
In the most recent fiscal year, Establishment Labs achieved revenue of $166M and an EBITDA of -$56.2M.
Establishment Labs expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Establishment Labs valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $165M | $166M | XXX | XXX | XXX |
| Gross Profit | $107M | $107M | XXX | XXX | XXX |
| Gross Margin | 65% | 64% | XXX | XXX | XXX |
| EBITDA | -$58.3M | -$56.2M | XXX | XXX | XXX |
| EBITDA Margin | -35% | -34% | XXX | XXX | XXX |
| Net Profit | -$75.2M | -$78.5M | XXX | XXX | XXX |
| Net Margin | -46% | -47% | XXX | XXX | XXX |
| Net Debt | $109M | $149M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Establishment Labs's stock price is $31.
Establishment Labs has current market cap of $905M, and EV of $1.0B.
See Establishment Labs trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.0B | $905M | XXX | XXX | XXX | XXX | $-2.73 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Establishment Labs has market cap of $905M and EV of $1.0B.
Establishment Labs's trades at 5.9x LTM EV/Revenue multiple, and -42.7x LTM EBITDA.
Analysts estimate Establishment Labs's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Establishment Labs and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $1.0B | XXX | XXX | XXX |
| EV/Revenue | 6.3x | XXX | XXX | XXX |
| EV/EBITDA | -18.5x | XXX | XXX | XXX |
| P/E | -10.7x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -14.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpEstablishment Labs's NTM/LTM revenue growth is 25%
Establishment Labs's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $0.2M for the same period.
Over next 12 months, Establishment Labs's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Establishment Labs's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Establishment Labs and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 1% | XXX | XXX | XXX | XXX |
| EBITDA Margin | -34% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -4% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | -9% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.2M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.2M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 12% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 96% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Establishment Labs acquired XXX companies to date.
Last acquisition by Establishment Labs was XXXXXXXX, XXXXX XXXXX XXXXXX . Establishment Labs acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Establishment Labs founded? | Establishment Labs was founded in 2004. |
| Where is Establishment Labs headquartered? | Establishment Labs is headquartered in United States of America. |
| How many employees does Establishment Labs have? | As of today, Establishment Labs has 1.0K+ employees. |
| Who is the CEO of Establishment Labs? | Establishment Labs's CEO is Mr. Fillipo Caldini. |
| Is Establishment Labs publicy listed? | Yes, Establishment Labs is a public company listed on NAS. |
| What is the stock symbol of Establishment Labs? | Establishment Labs trades under ESTA ticker. |
| When did Establishment Labs go public? | Establishment Labs went public in 2018. |
| Who are competitors of Establishment Labs? | Similar companies to Establishment Labs include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Establishment Labs? | Establishment Labs's current market cap is $905M |
| What is the current revenue of Establishment Labs? | Establishment Labs's last 12-month revenue is $178M. |
| What is the current EBITDA of Establishment Labs? | Establishment Labs's last 12-month EBITDA is -$24.4M. |
| What is the current EV/Revenue multiple of Establishment Labs? | Current revenue multiple of Establishment Labs is 5.9x. |
| What is the current EV/EBITDA multiple of Establishment Labs? | Current EBITDA multiple of Establishment Labs is -42.7x. |
| What is the current revenue growth of Establishment Labs? | Establishment Labs revenue growth between 2023 and 2024 was 1%. |
| Is Establishment Labs profitable? | Yes, Establishment Labs is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
